{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:12:07Z","timestamp":1790633527093,"version":"4.1.0"},"reference-count":49,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":3636,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Excess accumulation of advanced glycation end products (AGEs) contributes to aging and chronic diseases. We aimed to obtain evidence that exposure to AGEs plays a role in the development of type 1 diabetes (T1D).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>The effect of AGEs was examined on insulin secretion by MIN6N8 cells and mouse islets and in vivo in three separate rodent models: AGE-injected or high AGE\u2013fed Sprague-Dawley rats and nonobese diabetic (NODLt) mice. Rodents were also treated with the AGE-lowering agent alagebrium.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>\u03b2-Cells exposed to AGEs displayed acute glucose-stimulated insulin secretory defects, mitochondrial abnormalities including excess superoxide generation, a decline in ATP content, loss of MnSOD activity, reduced calcium flux, and increased glucose uptake, all of which were improved with alagebrium treatment or with MnSOD adenoviral overexpression. Isolated mouse islets exposed to AGEs had decreased glucose-stimulated insulin secretion, increased mitochondrial superoxide production, and depletion of ATP content, which were improved with alagebrium or with MnTBAP, an SOD mimetic. In rats, transient or chronic exposure to AGEs caused progressive insulin secretory defects, superoxide generation, and \u03b2-cell death, ameliorated with alagebrium. NODLt mice had increased circulating AGEs in association with an increase in islet mitochondrial superoxide generation, which was prevented by alagebrium, which also reduced the incidence of autoimmune diabetes. Finally, at-risk children who progressed to T1D had higher AGE concentrations than matched nonprogressors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>These findings demonstrate that AGEs directly cause insulin secretory defects, most likely by impairing mitochondrial function, which may contribute to the development of T1D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db10-1033","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T06:46:45Z","timestamp":1315896405000},"page":"2523-2532","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":144,"title":["Advanced Glycation End Products Are Direct Modulators of \u03b2-Cell Function"],"prefix":"10.2337","volume":"60","author":[{"given":"Melinda T.","family":"Coughlan","sequence":"first","affiliation":[{"name":"Division of Diabetes Complications, Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia Y.T.","family":"Yap","sequence":"additional","affiliation":[{"name":"Division of Diabetes Complications, Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.K.","family":"Tong","sequence":"additional","affiliation":[{"name":"Division of Diabetes Complications, Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofianos","family":"Andrikopoulos","sequence":"additional","affiliation":[{"name":"Department of Medicine, (AH\/NH) University of Melbourne, Heidelberg Repatriation Hospital, Heidelberg Heights, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gasser","sequence":"additional","affiliation":[{"name":"Division of Diabetes Complications, Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Thallas-Bonke","sequence":"additional","affiliation":[{"name":"Division of Diabetes Complications, Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Immunology and Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Division of Stem Cell Regulation Research, Osaka University Medical School, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Kay","sequence":"additional","affiliation":[{"name":"St. Vincent\u2019s Institute, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn M.","family":"Slattery","sequence":"additional","affiliation":[{"name":"Department of Immunology and Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Drew","sequence":"additional","affiliation":[{"name":"Clinical Physiology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn A.","family":"Kingwell","sequence":"additional","affiliation":[{"name":"Clinical Physiology, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Fourlanos","sequence":"additional","affiliation":[{"name":"Division of Autoimmunity and Transplantation, Walter and Eliza Hall Institute, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[{"name":"Department of Diabetes Genetics, Folkh\u00e4lsan Institute of Genetics, Folkh\u00e4lsan Research Center, Biomedicum, University of Helsinki, Helsinki, Finland"},{"name":"Department of Medicine, Division of Nephrology, Helsinki University Central Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard C.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Division of Autoimmunity and Transplantation, Walter and Eliza Hall Institute, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Knip","sequence":"additional","affiliation":[{"name":"Department of Diabetes Genetics, Folkh\u00e4lsan Institute of Genetics, Folkh\u00e4lsan Research Center, Biomedicum, University of Helsinki, Helsinki, Finland"},{"name":"Hospital for Children and Adolescents, University of Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Forbes","sequence":"additional","affiliation":[{"name":"Division of Diabetes Complications, Diabetes and Metabolism Division, Baker IDI Heart and Diabetes Institute, Melbourne, Australia"},{"name":"Department of Immunology and Medicine, Monash University, Melbourne, Australia"},{"name":"Mater Medical Research Institute, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2011,9,16]]},"reference":[{"key":"2022031222520315400_B1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature06406","article-title":"Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A","volume":"450","author":"Nejentsev","year":"2007","journal-title":"Nature"},{"key":"2022031222520315400_B2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(08)60765-5","article-title":"Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study","volume":"371","author":"Harjutsalo","year":"2008","journal-title":"Lancet"},{"key":"2022031222520315400_B3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2337\/dc08-0239","article-title":"The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes","volume":"31","author":"Fourlanos","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031222520315400_B4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1034\/j.1399-0039.2003.00071.x","article-title":"HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families","volume":"62","author":"Hermann","year":"2003","journal-title":"Tissue Antigens"},{"key":"2022031222520315400_B5","first-page":"66","article-title":"Action des acides amines sur les sucres: formation des melanoidines par voie methodique [article in French].","volume":"154","author":"Maillard","year":"1912","journal-title":"Acad Sci"},{"key":"2022031222520315400_B6","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.2337\/diabetes.51.11.3274","article-title":"Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy","volume":"51","author":"Forbes","year":"2002","journal-title":"Diabetes"},{"key":"2022031222520315400_B7","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1096\/fj.02-1102fje","article-title":"The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes","volume":"17","author":"Forbes","year":"2003","journal-title":"FASEB J"},{"key":"2022031222520315400_B8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/diabetes.53.7.1813","article-title":"Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis","volume":"53","author":"Forbes","year":"2004","journal-title":"Diabetes"},{"key":"2022031222520315400_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","article-title":"Role of oxidative stress in diabetic complications: a new perspective on an old paradigm","volume":"48","author":"Baynes","year":"1999","journal-title":"Diabetes"},{"key":"2022031222520315400_B10","doi-asserted-by":"crossref","first-page":"21597","DOI":"10.1016\/S0021-9258(20)88225-8","article-title":"Structure and elucidation of a senescence cross-link from human extracellualr matrix","volume":"264","author":"Sell","year":"1989","journal-title":"J Biol Chem"},{"key":"2022031222520315400_B11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ki.1997.160","article-title":"Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure","volume":"51","author":"Miyata","year":"1997","journal-title":"Kidney Int"},{"key":"2022031222520315400_B12","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1002\/art.23042","article-title":"Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12","volume":"56","author":"Wittkowski","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022031222520315400_B13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2353\/ajpath.2008.080152","article-title":"Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan","volume":"173","author":"Cai","year":"2008","journal-title":"Am J Pathol"},{"key":"2022031222520315400_B14","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2337\/diabetes.51.7.2082","article-title":"Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db\/db mouse","volume":"51","author":"Hofmann","year":"2002","journal-title":"Diabetes"},{"key":"2022031222520315400_B15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2337\/diabetes.52.6.1441","article-title":"Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice","volume":"52","author":"Peppa","year":"2003","journal-title":"Diabetes"},{"key":"2022031222520315400_B16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/dc10-1058","article-title":"Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes?","volume":"33","author":"Mericq","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031222520315400_B17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/en.2008-1342","article-title":"Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis","volume":"150","author":"Zhao","year":"2009","journal-title":"Endocrinology"},{"key":"2022031222520315400_B18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5694\/j.1326-5377.1998.tb140188.x","article-title":"The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing","volume":"169","author":"Colman","year":"1998","journal-title":"Med J Aust"},{"key":"2022031222520315400_B19","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00125-004-1507-3","article-title":"Insulin resistance is a risk factor for progression to type 1 diabetes","volume":"47","author":"Fourlanos","year":"2004","journal-title":"Diabetologia"},{"key":"2022031222520315400_B20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/en.2006-1300","article-title":"Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?","volume":"148","author":"Coughlan","year":"2007","journal-title":"Endocrinology"},{"key":"2022031222520315400_B21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo-127-1-126","article-title":"Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms","volume":"127","author":"Miyazaki","year":"1990","journal-title":"Endocrinology"},{"key":"2022031222520315400_B22","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2337\/db05-1404","article-title":"Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase","volume":"55","author":"Carey","year":"2006","journal-title":"Diabetes"},{"key":"2022031222520315400_B23","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/db07-1326","article-title":"Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function","volume":"57","author":"Kebede","year":"2008","journal-title":"Diabetes"},{"key":"2022031222520315400_B24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2362.2002.01011.x","article-title":"Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients","volume":"32","author":"Schalkwijk","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"2022031222520315400_B25","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI11951","article-title":"Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)","volume":"108","author":"Oldfield","year":"2001","journal-title":"J Clin Invest"},{"key":"2022031222520315400_B26","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1172\/JCI116481","article-title":"Accumulation of Maillard reaction products in skin collagen in diabetes and aging","volume":"91","author":"Dyer","year":"1993","journal-title":"J Clin Invest"},{"key":"2022031222520315400_B27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","article-title":"A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes","volume":"92","author":"Candido","year":"2003","journal-title":"Circ Res"},{"key":"2022031222520315400_B28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s001250051587","article-title":"Renoprotective effects of a novel inhibitor of advanced glycation","volume":"44","author":"Forbes","year":"2001","journal-title":"Diabetologia"},{"key":"2022031222520315400_B29","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1046\/j.1523-1755.2000.00097.x","article-title":"Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat","volume":"57","author":"Forbes","year":"2000","journal-title":"Kidney Int"},{"key":"2022031222520315400_B30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/joe.1.06333","article-title":"Differential effect of inbred mouse strain (C57BL\/6, DBA\/2, 129T2) on insulin secretory function in response to a high fat diet","volume":"187","author":"Andrikopoulos","year":"2005","journal-title":"J Endocrinol"},{"key":"2022031222520315400_B31","doi-asserted-by":"crossref","first-page":"R1259","DOI":"10.1152\/ajpregu.00264.2003","article-title":"Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction","volume":"285","author":"Drew","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022031222520315400_B32","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products","volume":"94","author":"Cerami","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031222520315400_B33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1172\/JCI119126","article-title":"Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells","volume":"99","author":"Matsuoka","year":"1997","journal-title":"J Clin Invest"},{"key":"2022031222520315400_B34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1155\/EDR.2000.111","article-title":"Aminoguanidine exerts a beta-cell function-preserving effect in high glucose-cultured beta-cells (INS-1)","volume":"1","author":"Tajiri","year":"2000","journal-title":"Int J Exp Diabetes Res"},{"key":"2022031222520315400_B35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/dc07-0103","article-title":"Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)","volume":"31","author":"Bingley","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031222520315400_B36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/diab.35.4.486","article-title":"Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse","volume":"35","author":"Kano","year":"1986","journal-title":"Diabetes"},{"key":"2022031222520315400_B37","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/diabetes.54.8.2314","article-title":"Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake","volume":"54","author":"Sandu","year":"2005","journal-title":"Diabetes"},{"key":"2022031222520315400_B38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20030800","article-title":"The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment","volume":"198","author":"Chavakis","year":"2003","journal-title":"J Exp Med"},{"key":"2022031222520315400_B39","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.4049\/jimmunol.181.6.4272","article-title":"RAGE ligation affects T cell activation and controls T cell differentiation","volume":"181","author":"Chen","year":"2008","journal-title":"J Immunol"},{"key":"2022031222520315400_B40","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.173.2.1399","article-title":"Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products","volume":"173","author":"Chen","year":"2004","journal-title":"J Immunol"},{"key":"2022031222520315400_B41","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00125-011-2058-z","article-title":"Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes","volume":"54","author":"Forbes","year":"2011","journal-title":"Diabetologia"},{"key":"2022031222520315400_B42","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI200319774","article-title":"Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction","volume":"112","author":"Krauss","year":"2003","journal-title":"J Clin Invest"},{"key":"2022031222520315400_B43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes","volume":"350","author":"Petersen","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031222520315400_B44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jnnp.31.3.226","article-title":"Diabetes mellitus in Friedreich\u2019s ataxia","volume":"31","author":"Hewer","year":"1968","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022031222520315400_B45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1042\/bj3200855","article-title":"Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction","volume":"320","author":"Kaneto","year":"1996","journal-title":"Biochem J"},{"key":"2022031222520315400_B46","first-page":"79","article-title":"Effects of AGEs on oxidation stress and antioxidation abilities in cultured astrocytes","volume":"17","author":"Jiang","year":"2004","journal-title":"Biomed Environ Sci"},{"key":"2022031222520315400_B47","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/meta.2001.25802","article-title":"Overexpression of manganese superoxide dismutase suppresses increases in collagen accumulation induced by culture of mesangial cells in high-media glucose","volume":"50","author":"Craven","year":"2001","journal-title":"Metabolism"},{"key":"2022031222520315400_B48","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1172\/JCI1489","article-title":"Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta-induced cytotoxicity and reduces nitric oxide production","volume":"101","author":"Hohmeier","year":"1998","journal-title":"J Clin Invest"},{"key":"2022031222520315400_B49","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1006\/jmcc.1998.0789","article-title":"Overexpression of MnSOD protects against myocardial ischemia\/reperfusion injury in transgenic mice","volume":"30","author":"Chen","year":"1998","journal-title":"J Mol Cell Cardiol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/60\/10\/2523\/398055\/2523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/60\/10\/2523\/398055\/2523.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:24:16Z","timestamp":1667406256000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/60\/10\/2523\/33457\/Advanced-Glycation-End-Products-Are-Direct"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,16]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,9,16]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db10-1033","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,16]]}}}